Neeser J R, Chambaz A, Del Vedovo S, Prigent M J, Guggenheim B
Nestlé Research Centre, Nestec Limited, Lausanne, Switzerland.
Infect Immun. 1988 Dec;56(12):3201-8. doi: 10.1128/iai.56.12.3201-3208.1988.
Various caseinoglycopeptide derivatives prepared from mammalian milk were evaluated as inhibitors of hemagglutinations mediated by Actinomyces viscosus Ny1, Streptococcus sanguis OMZ9, and, for comparative purposes, plant lectins from Arachis hypogaea and Bauhinia purpurea. It was found that recognition of the beta-D-galactose-(1----3)-2-acetamido-2-deoxy-D-galactose carbohydrate chain by Actinomyces viscosus Ny1 organisms and Arachis hypogaea and B. purpurea agglutinins had similar structural requirements; in all cases, the desialylated bovine caseinoglycomacropeptide, on which several units of the above mentioned disaccharide are clustered, behaved as the most potent hemagglutination inhibitor. By contrast, none of the preparations tested inhibited erythrocyte agglutination by S. sanguis OMZ9. Thus, the desialylated bovine caseinoglycomacropeptide acts as a potent and specific inhibitor of oral Actinomyces adhesion to cell membranes (a soft surface) and could be used as a probe for the study of recognition mechanisms mediated by Actinomyces galactose-binding lectins. During the present study, both native and desialylated variants of the same bovine glycomacropeptide also totally prevented the adhesion of Actinomyces viscosus Ny1, S. sanguis OMZ9, and S. mutans OMZ176 to polystyrene surfaces. Comparative evaluations of various structurally different compounds gave the following results. Neither mono- nor disaccharides related to caseinoglycopeptide carbohydrates prevented adhesion; highly positively or negatively charged polypeptides and polysaccharides were either not or only moderately active. Besides these glycomacropeptides, an inhibitory activity was also exhibited by other mucin-type glycoproteins carrying short O-linked carbohydrate chains (including bovine submaxillary mucin), polyethylene glycol, and bovine serum albumin. Consequently, caseinoglycopeptide prevention of oral bacterial adhesion to polystyrene tubes (a hard surface) takes place with no species specificity and can be compared to nonspecific inhibition exhibited by various polymers with very different structural characteristics.
对从哺乳动物乳汁中制备的各种酪蛋白糖肽衍生物进行了评估,以确定它们作为黏性放线菌Ny1、血链球菌OMZ9介导的血凝反应抑制剂的效果,并且为了进行比较,还评估了它们对来自花生和紫羊蹄甲的植物凝集素介导的血凝反应的抑制效果。结果发现,黏性放线菌Ny1菌株以及花生和紫羊蹄甲凝集素对β-D-半乳糖-(1→3)-2-乙酰氨基-2-脱氧-D-半乳糖碳水化合物链的识别具有相似的结构要求;在所有情况下,上述二糖的几个单元聚集在其上的去唾液酸牛酪蛋白糖巨肽表现为最有效的血凝抑制剂。相比之下,所测试的制剂均未抑制血链球菌OMZ9引起的红细胞凝集。因此,去唾液酸牛酪蛋白糖巨肽可作为口腔放线菌黏附于细胞膜(软表面)的有效且特异性抑制剂,并可作为研究由放线菌半乳糖结合凝集素介导的识别机制的探针。在本研究中,同一牛糖巨肽的天然变体和去唾液酸变体也完全阻止了黏性放线菌Ny1、血链球菌OMZ9和变形链球菌OMZ176黏附于聚苯乙烯表面。对各种结构不同的化合物进行的比较评估得出了以下结果。与酪蛋白糖肽碳水化合物相关的单糖或二糖均不能阻止黏附;高正电荷或高负电荷的多肽和多糖要么没有活性,要么只有中等活性。除了这些糖巨肽外,其他带有短O-连接碳水化合物链的黏蛋白型糖蛋白(包括牛颌下黏蛋白)、聚乙二醇和牛血清白蛋白也表现出抑制活性。因此,酪蛋白糖肽阻止口腔细菌黏附于聚苯乙烯管(硬表面)的过程没有物种特异性,并且可以与具有非常不同结构特征的各种聚合物所表现出的非特异性抑制作用相比较。